相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Overexpression of CYP2J2 provides protection against doxorubicin-induced cardiotoxicity
Yunfang Zhang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Mammalian epoxide hydrolases in xenobiotic metabolism and signalling
Martina Decker et al.
ARCHIVES OF TOXICOLOGY (2009)
Inhibition of Soluble Epoxide Hydrolase Attenuated Atherosclerosis, Abdominal Aortic Aneurysm Formation, and Dyslipidemia
Le-Ning Zhang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Discovery of 3,3-disubstituted piperidine-derived trisubstituted ureas as highly potent soluble epoxide hydrolase inhibitors
Hong C. Shen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Discovery of spirocyclic secondary amine-derived tertiary ureas as highly potent, selective and bioavailable soluble epoxide hydrolase inhibitors
Hong C. Shen et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Pharmacokinetic optimization of four soluble epoxide hydrolase inhibitors for use in a murine model of inflammation
Jun-Yan Liu et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Soluble Epoxide Hydrolase, a Target with Multiple Opportunities for Cardiovascular Drug Discovery
Joseph P. Marino
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2009)
The mechanism and significance of the slow changes of ventricular action potential duration following a change of heart rate
D. A. Eisner et al.
EXPERIMENTAL PHYSIOLOGY (2009)
Beneficial effects of soluble epoxide hydrolase inhibitors in myocardial infarction model: Insight gained using metabolomic approaches
Ning Li et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Epoxyeicosatrienoic acid prevents postischemic electrocardiogram abnormalities in an isolated heart model
S. N. Batchu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Soluble epoxide hydrolase plays an essential role in angiotensin II-induced cardiac hypertrophy
Ding Ai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Multiple antiapoptotic targets of the PI3K/Akt survival pathway are activated by epoxyeicosatrienoic acids to protect cardiomyocytes from hypoxia/anoxia
Anuradha Dhanasekaran et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Effects of the selective EET antagonist, 14,15-EEZE, on cardioprotection produced by exogenous or endogenous EETs in the canine heart
Garrett J. Gross et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Soluble epoxide hydrolase inhibition and gene deletion are protective against myocardial ischemia-reperfusion injury in vivo
Atsuko Motoki et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2008)
Transcriptional regulation of the human soluble epoxide hydrolase gene EPHX2
Hiromasa Tanaka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2008)
Soluble epoxide hydrolase inhibitor, AUDA, prevents early salt-sensitive hypertension
Jing Li et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat
Mandi J. Corenblum et al.
HYPERTENSION (2008)
Soluble Epoxide Hydrolase Inhibitors Reduce the Development of Atherosclerosis in Apolipoprotein E-Knockout Mouse Model
Arzu Ulu et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease
Jan Monti et al.
NATURE GENETICS (2008)
Gerry Brooks and epoxide hydrolases: four decades to a pharmaceutical
Christophe Morisseau et al.
PEST MANAGEMENT SCIENCE (2008)
Soluble epoxide hydrolase gene deletion reduces survival after cardiac arrest and cardiopulmonary resuscitation
Michael P. Hutchens et al.
RESUSCITATION (2008)
Orally bioavailable potent soluble epoxide hydrolase inhibitors
Sung Hee Hwang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2007)
Heart disease and stroke statistics - 2007 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Wayne Rosamond et al.
CIRCULATION (2007)
Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice
Ayala Luria et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Soluble epoxide hydrolase inhibition reveals novel biological functions of epoxyeicosatrienoic acids (EETs)
Bora Inceoglu et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2007)
The soluble epoxide hydrolase as a pharmaceutical target for hypertension
Nipavan Chiamvimonvat et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2007)
Protection conferred by myocardial ATP-sensitive K+ channels in pressure overload-induced congestive heart failure revealed in KCNJ11 Kir6.2-null mutant
Satsuki Yamada et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Prevention and reversal of cardiac hypertrophy by soluble epoxide hydrolase inhibitors
Danyan Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Synthesis and SAR of conformationally restricted inhibitors of soluble epoxide hydrolase
Paul D. Jones et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Regulating the regulator:: NF-κB signaling in heart
Gentzon Hall et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2006)
Enhancement of antinociception by coadministration of nonsteroidal anti-inflammatory drugs and soluble epoxide hydrolase inhibitors
Kara R. Schmelzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Role of soluble epoxide hydrolase in postischemic recovery of heart contractile function
John M. Seubert et al.
CIRCULATION RESEARCH (2006)
Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury
Kasem Nithipatikom et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease:: The Atherosclerosis Risk in Communities (ARIC) study
CR Lee et al.
HUMAN MOLECULAR GENETICS (2006)
Emerging role of epoxyeicosatrienoic acids in coronary vascular function
BT Larsen et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2006)
Cytochrome P450 epoxygenase gene function in hypoxic pulmonary vasoconstriction and pulmonary vascular remodeling
P Pokreisz et al.
HYPERTENSION (2006)
Reticulocyte 15-lipoxygenase-I is important in acetylcholine-induced endothelium-dependent vasorelaxation in rabbit aorta
X Tang et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2006)
An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension
JD Imig et al.
HYPERTENSION (2005)
Soluble epoxide hydrolase is a therapeutic target for acute inflammation
KR Schmelzer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
KATP channels and preconditioning:: A re-examination of the role of mitochondrial KATpchannels and an overview of alternative mechanisms
PJ Hanley et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility
IH Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Requirement of nuclear factor-κB in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo
C Freund et al.
CIRCULATION (2005)
Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension
O Jung et al.
HYPERTENSION (2005)
14,15-epoxyeicosatrienoic acid represents a transferable endothelium-dependent relaxing factor in bovine coronary arteries
KM Gauthier et al.
HYPERTENSION (2005)
Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids
M Spiecker et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
Structure of human epoxide hydrolase reveals mechanistic inferences on bifunctional catalysis in epoxide and phosphate ester hydrolysis
GA Gomez et al.
BIOCHEMISTRY (2004)
Design, synthesis, and biological activity of 1,3-Disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility
IH Kim et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
NF-κB and reperfusion injury
TC Nichols
DRUG NEWS & PERSPECTIVES (2004)
Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway
J Seubert et al.
CIRCULATION RESEARCH (2004)
Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure
K Sekiguchi et al.
CARDIOVASCULAR RESEARCH (2004)
Risk of coronary artery disease associated with polymorphism of the cytochrome P450 epoxygenase CYP2J2
M Spiecker et al.
CIRCULATION (2004)
Dietary fish oil dose- and time-response effects on cardiac phospholipid fatty acid composition
AJ Owen et al.
LIPIDS (2004)
Polymorphisms in human soluble epoxide hydrolase
BD Przybyla-Zawislak et al.
MOLECULAR PHARMACOLOGY (2003)
QSAR and classification of murine and human soluble epoxide hydrolase inhibition by urea-like compounds
NR McElroy et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphatase
A Cronin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cardiac hypertrophy: The good, the bad and the ugly
N Frey et al.
ANNUAL REVIEW OF PHYSIOLOGY (2003)
Cytochrome P-450 epoxygenase metabolites of docosahexaenoate potently dilate coronary Arterioles by activating large-conductance calcium-activated potassium channels
D Ye et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Cytoprotective role of Ca2+-activated K+ channels in the cardiac inner mitochondrial membrane
WH Xu et al.
SCIENCE (2002)
Polymorphism in soluble epoxide hydrolase and blood pressure in spontaneously hypertensive rats
M Fornage et al.
HYPERTENSION (2002)
Structural refinement of inhibitors of urea-based soluble epoxide hydrolases
C Morisseau et al.
BIOCHEMICAL PHARMACOLOGY (2002)
Trophic effects of the cyclooxygenase-2 product prostaglandin E2 in cardiac myocytes
M Mendez et al.
HYPERTENSION (2002)
Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension
JD Imig et al.
HYPERTENSION (2002)
Seventy genetic variations in human microsomal and soluble epoxide hydrolase genes (EPHX1 and EPHX2) in the Japanese population
S Saito et al.
JOURNAL OF HUMAN GENETICS (2001)
Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation
CJ Sinal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids
ZG Yu et al.
CIRCULATION RESEARCH (2000)
3-D QSAR analysis of inhibition of murine soluble epoxide hydrolase (MsEH) by benzoylureas, arylureas, and their analogues
Y Nakagawa et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2000)
Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms
M Sandberg et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation
MA Argiriadi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
